Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Decontamination in Pediatric HSCT
NCT02641236Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Mar 2016
- Primary completion
- Apr 2021
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin, polymyxin B in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Dana-Farber Cancer Institute. Started Mar 2016; status: completed.
02
Drugs
vancomycinpolymyxin B
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT02641236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641236.